Sunovion Pharmaceuticals and the American College of Chest Physicians yesterday launched a strategic initiative called Delivery Makes a Difference to better understand patient and healthcare provider practices in COPD therapy.
A series of “nationally recognized COPD thought leaders” came together to be a part of the steering committee for the initiative. They developed a survey for 1,000 patients and providers to assess drug-device prescription habits. The team also hopes to gain insight into perception disparities between patients and health care providers.
Get the full story at our sister site, Drug Delivery Business News.
The post Sunovion, medical society ally for COPD drug-delivery survey appeared first on MassDevice.
from MassDevice http://ift.tt/2eqQ3Z2
Cap comentari:
Publica un comentari a l'entrada